Download PDF

Human Genetics

Publication date: 2016-01-01
Volume: 135 Pages: 137 - 154
Publisher: Springer-Verlag

Author:

Lei, Jieping
Rudolph, Anja ; Chang-Claude, Jenny ; Moysich, Kirsten B ; Van Dyck, Laurien ; Behrens, Sabine ; Goode, Ellen L ; Bolla, Manjeet K ; Dennis, Joe ; Dunning, Alison M ; Easton, Douglas F ; Wang, Qin ; Benitez, Javier ; Hopper, John L ; Southey, Melissa C ; Schmidt, Marjanka K ; Broeks, Annegien ; Fasching, Peter A ; Haeberle, Lothar ; Peto, Julian ; Dos-Santos-Silva, Isabel ; Sawyer, Elinor J ; Tomlinson, Ian ; Burwinkel, Barbara ; Marmé, Frederik ; Guénel, Pascal ; Truong, Thérèse ; Bojesen, Stig E ; Flyger, Henrik ; Nielsen, Sune F ; Nordestgaard, Børge G ; González-Neira, Anna ; Menéndez, Primitiva ; Anton-Culver, Hoda ; Neuhausen, Susan L ; Brenner, Hermann ; Arndt, Volker ; Meindl, Alfons ; Schmutzler, Rita K ; Brauch, Hiltrud ; Hamann, Ute ; Nevanlinna, Heli ; Fagerholm, Rainer ; Dörk, Thilo ; Bogdanova, Natalia V ; Mannermaa, Arto ; Hartikainen, Jaana M ; Van Dijck, Laurien ; Smeets, Ann ; Flesch-Janys, Dieter ; Eilber, Ursula ; Radice, Paolo ; Peterlongo, Paolo ; Couch, Fergus J ; Hallberg, Emily ; Giles, Graham G ; Milne, Roger L ; Haiman, Christopher A ; Schumacher, Fredrick ; Simard, Jacques ; Goldberg, Mark S ; Kristensen, Vessela ; Borresen-Dale, Anne-Lise ; Zheng, Wei ; Beeghly-Fadiel, Alicia ; Winqvist, Robert ; Grip, Mervi ; Andrulis, Irene L ; Glendon, Gord ; García-Closas, Montserrat ; Figueroa, Jonine ; Czene, Kamila ; Brand, Judith S ; Darabi, Hatef ; Eriksson, Mikael ; Hall, Per ; Li, Jingmei ; Cox, Angela ; Cross, Simon S ; Pharoah, Paul DP ; Shah, Mitul ; Kabisch, Maria ; Torres, Diana ; Jakubowska, Anna ; Lubinski, Jan ; Ademuyiwa, Foluso ; Ambrosone, Christine B ; Swerdlow, Anthony ; Jones, Michael

Keywords:

Genetic variation, immunosuppression, Science & Technology, Life Sciences & Biomedicine, Genetics & Heredity, GENOME-WIDE ASSOCIATION, REGULATORY T-CELLS, SUPPRESSOR-CELLS, TUMOR MICROENVIRONMENT, IMMUNE SURVEILLANCE, CROHNS-DISEASE, LOCI, RISK, INFLAMMATION, VISUALIZATION, Breast Neoplasms, Case-Control Studies, Female, Genetic Predisposition to Disease, Humans, Immune Tolerance, Polymorphism, Single Nucleotide, Australian Ovarian Study Group, kConFab Investigators, 0604 Genetics, 1104 Complementary and Alternative Medicine, 1114 Paediatrics and Reproductive Medicine, 3105 Genetics, 3215 Reproductive medicine

Abstract:

mmunosuppression plays a pivotal role in assisting tumors to evade immune destruction and pro- moting tumor development. We hypothesized that genetic variation in the immunosuppression pathway genes may be implicated in breast cancer tumorigenesis. We included 42,510 female breast cancer cases and 40,577 controls of European ancestry from 37 studies in the Breast Cancer Association Consortium (2015) with available genotype data for 3595 single nucleotide polymorphisms (SNPs) in 133 candidate genes. Associations between genotyped SNPs and overall breast cancer risk, and secondarily according to estrogen receptor (ER) status, were assessed using multiple logistic regression models. Gene-level associations were assessed based on principal component analysis. Gene expression analyses were conducted using RNA sequencing level 3 data from The Cancer Genome Atlas for 989 breast tumor samples and 113 matched nor- mal tissue samples. SNP rs1905339 (A[G) in the STAT3 region was associated with an increased breast cancer risk (per allele odds ratio 1.05, 95 % confidence interval 1.03–1.08; p value = 1.4 9 10-6). The association did not differ significantly by ER status. On the gene level, in addition to TGFBR2 and CCND1, IL5 and GM-CSF showed the strongest associations with overall breast can- cer risk (p value = 1.0 9 10-3 and 7.0 9 10-3, respec- tively). Furthermore, STAT3 and IL5 but not GM-CSF were differentially expressed between breast tumor tissue and normal tissue (p value = 2.5 9 10-3, 4.5 9 10-4 and 0.63, respectively). Our data provide evidence that the immunosuppression pathway genes STAT3, IL5, and GM- CSF may be novel susceptibility loci for breast cancer in women of European ancestry.